GB0715949A
GB0715949D0
(en)
|
2007-08-15 |
2007-08-15 |
Peptide with improved solubility
|
ES08750553T
ES2425486T3
(en)
|
2007-05-09 |
2008-05-09 |
Prognosis analysis to determine the response of T cells to HLA antigens and their use in the field of tissue transplantation
|
EP08750553.3A
EP2156183B1
(en)
|
2007-05-09 |
2008-05-09 |
Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
|
PCT/GB2008/001614
WO2008139163A1
(en)
|
2007-05-09 |
2008-05-09 |
Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
|
US12/599,264
US20110038881A1
(en)
|
2007-05-09 |
2008-05-09 |
Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
|
PL08788348T
PL2083856T3
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
KR1020107005503A
KR101699554B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for vaccine
|
ES08788348T
ES2353362T3
(en)
|
2007-08-15 |
2008-08-15 |
PEPTIDES FOR INSENSITIZATION AGAINST ALLERGENS.
|
PCT/GB2008/002779
WO2009022155A2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
EA201070271A
EA023303B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptide composition for tolerization to house dust mites and use thereof
|
EA201070270A
EA018110B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides with reduced dimer formation
|
NZ583362A
NZ583362A
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
MX2010001779A
MX2010001779A
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens.
|
US12/673,334
US8551493B2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
DE602008002810T
DE602008002810D1
(en)
|
2007-08-15 |
2008-08-15 |
PEPTIDES FOR DESENSIBILIZING AGAINST ALLERGENIC
|
EP08788347A
EP2190473B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
CN2008801116120A
CN101820907B
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with multiple epitopes
|
JP2010520628A
JP5697447B2
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensitization to allergens
|
AU2008288283A
AU2008288283B2
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
PT111781811T
PT2397154E
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
PCT/GB2008/002781
WO2009022157A2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with improved solubility
|
DK08788347.6T
DK2190473T3
(en)
|
2007-08-15 |
2008-08-15 |
PEPTID WITH REDUCED DIMERING
|
US12/673,386
US9340580B2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with multiple epitopes
|
EP08788348A
EP2083856B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
ES08788347T
ES2402956T3
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
PCT/GB2008/002780
WO2009022156A2
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
US12/673,412
US8652485B2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide for vaccine
|
AT08788348T
ATE482721T1
(en)
|
2007-08-15 |
2008-08-15 |
PEPTIDES FOR DESENSITIZATION TO ALLERGENS
|
BRPI0815395-7A2A
BRPI0815395A2
(en)
|
2007-08-15 |
2008-08-15 |
COMPOSITION, VECTOR, PRODUCT, PHARMACEUTICAL FORMULATION, IN VITRO METHOD TO DETERMINE IF T-CELLS RECOGNIZE A POLYPEPTIDE, AND IN VITRO METHOD TO DETERMINE IF AN INDIVIDUAL IS OR IS AT RISK.
|
DK08788348.4T
DK2083856T3
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensitization to allergens
|
PT08788348T
PT2083856E
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
EP11178181.1A
EP2397154B1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
EP10006685A
EP2286833A3
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
PCT/GB2008/002778
WO2009022154A2
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with multiple epitopes
|
SI200830933T
SI2190473T1
(en)
|
2007-08-15 |
2008-08-15 |
Peptide with reduced dimer formation
|
CA2696563A
CA2696563A1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for vaccine
|
NZ583361A
NZ583361A
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
SI200830119T
SI2083856T1
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
CN201310140326.XA
CN103272227B
(en)
|
2007-08-15 |
2008-08-15 |
Peptides for desensibilization against allergens
|
HK09112173.5A
HK1132194A1
(en)
|
2007-08-15 |
2009-12-24 |
Peptides for desensibilization against allergens
|
ZA2010/01056A
ZA201001056B
(en)
|
2007-08-15 |
2010-02-12 |
Peptides for desensibilization against allergens
|
ZA2010/01054A
ZA201001054B
(en)
|
2007-08-15 |
2010-02-12 |
Peptide with reduced dimer formation
|
IL203943A
IL203943A
(en)
|
2007-08-15 |
2010-02-14 |
Composition comprising peptide for preventing or treating allergy to house dust mite
|
HR20100662T
HRP20100662T1
(en)
|
2007-08-15 |
2010-12-01 |
Peptides for desensibilization against allergens
|
CY20101101127T
CY1110981T1
(en)
|
2007-08-15 |
2010-12-07 |
DESCRIPTION DESCRIPTION AGAINST ALLERGYOGENES
|
HK12105353.6A
HK1164700A1
(en)
|
2007-08-15 |
2012-06-01 |
Peptides for desensibilization against allergens
|
HRP20130270AT
HRP20130270T1
(en)
|
2007-08-15 |
2013-03-25 |
Peptide with reduced dimer formation
|
US13/974,603
US20130336999A1
(en)
|
2007-08-15 |
2013-08-23 |
Peptide with reduced dimer formation
|
US14/150,045
US20140186403A1
(en)
|
2007-08-15 |
2014-01-08 |
Peptide for vaccine
|
JP2014204979A
JP6040207B2
(en)
|
2007-08-15 |
2014-10-03 |
Peptides for desensitization to allergens
|
CY20151100901T
CY1116828T1
(en)
|
2007-08-15 |
2015-10-07 |
PATIENTS FOR DESCRIPTION FROM ALLERGIANS
|
US15/095,480
US20160289281A1
(en)
|
2007-08-15 |
2016-04-11 |
Peptide with multiple epitopes
|
JP2016191563A
JP2017061455A
(en)
|
2007-08-15 |
2016-09-29 |
Peptides for desensitization to allergen
|
US15/294,973
US9744222B2
(en)
|
2007-08-15 |
2016-10-17 |
Peptide for vaccine
|